Engineered extracellular vesicles show promise in targeting cancer cells and immunosuppressive stromal cells, offering a ...

Hinge Bio, Inc., a privately-held biotechnology company, today announced the close of a Series A’ financing led by Point72. Joining Point72 are Ridgeback Capital, InVivium Capital, and Lightswitch ...

新京报讯 ...

在该研究中，陆佩华院长带领团队创新性地采用基于纳米抗体的CD7 CAR-T治疗急性髓系白血病，研究结果不仅在肿瘤杀伤力和安全性上取得了显著进展，更为难治复发急性髓系白血病的治疗开辟了新路径。

NDAQ:CRBU) Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025 ...

VIR-5818 is under clinical development by Vir Biotechnology and currently in Phase II for Metastatic Colorectal Cancer.